Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland

PURPOSE: Oncology drugs are often approved for multiple indications, for which their clinical benefit varies. Aligning a single price to this differing value remains a challenge. This study examines the clinical and economic value, price, and reimbursement of multi-indication cancer drugs across sev...

Descripción completa

Detalles Bibliográficos
Autores principales: Michaeli, Daniel Tobias, Mills, Mackenzie, Kanavos, Panos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385843/
https://www.ncbi.nlm.nih.gov/pubmed/35821360
http://dx.doi.org/10.1007/s40258-022-00737-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9385843/
https://www.ncbi.nlm.nih.gov/pubmed/35821360
http://dx.doi.org/10.1007/s40258-022-00737-w

Ejemplares similares